Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -766,409 | -461,203 | -213,416 | -600,093 | -405,524 |
| Depreciation Amortization | -11,421 | -10,042 | -6,101 | -32,741 | -27,302 |
| Income taxes - deferred | N/A | N/A | N/A | -762 | N/A |
| Accounts receivable | N/A | N/A | N/A | 1,254 | 1,254 |
| Accounts payable and accrued liabilities | 20,036 | 491 | -8,270 | -6,465 | -35,828 |
| Other Working Capital | 54,577 | -1,866 | 2,437 | 1,168 | -41,614 |
| Other Operating Activity | 79,714 | 56,428 | 30,915 | 80,203 | 89,868 |
| Operating Cash Flow | $-623,503 | $-416,192 | $-194,435 | $-557,436 | $-419,146 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,241 | 29,043 | -12,683 | -544,086 | -152,405 |
| PPE Investments | -14,065 | -10,716 | -3,266 | -10,308 | -9,086 |
| Investing Cash Flow | $43,176 | $18,327 | $-15,949 | $-554,394 | $-161,491 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 244,215 | 250,000 | N/A | N/A | N/A |
| Common Stock Issued | 11,621 | 7,473 | 892 | 959,129 | 85,608 |
| Other Financing Activity | 29 | -16 | -18 | 284 | 0 |
| Financing Cash Flow | $255,865 | $257,457 | $874 | $959,413 | $85,608 |
| Beginning Cash Position | 546,762 | 546,762 | 546,762 | 699,179 | 699,179 |
| End Cash Position | 222,300 | 406,354 | 337,252 | 546,762 | 204,150 |
| Net Cash Flow | $-324,462 | $-140,408 | $-209,510 | $-152,417 | $-495,029 |
| Free Cash Flow | |||||
| Operating Cash Flow | -623,503 | -416,192 | -194,435 | -557,436 | -419,146 |
| Capital Expenditure | -14,065 | -10,716 | -3,266 | -10,308 | -9,086 |
| Free Cash Flow | -637,568 | -426,908 | -197,701 | -567,744 | -428,232 |